Dishman Pharma reports 10-fold increase in Q3 consolidated net

Dishman Pharmaceuticals and Chemicals has reported about 10-fold increase in its consolidated net profit at Rs 16.72 crore for the quarter ended December 31. The company had posted a net profit of Rs 1.68 crore in the corresponding period last financial year.

The consolidated total income during the quarter under review also went up by 11.89% to Rs 266.19 crore from Rs 237.89 crore in the year-ago period.